Avoiding reoperation for indeterminate thyroid nodules identified as malignant after surgery

Journal Article · Wed May 01 04:00:00 EDT 1991 · Archives of Surgery (Chicago); (USA)

DOI:https://doi.org/10.1001/archsurg.1991.01410290074015· OSTI ID:5768611

Block, M A; Dailey, G.E. 3d.; Muchmore, D ^[1]

---

1. Scripps Clinic Medical Group Inc, La Jolla, CA (USA)

Thyroid nodules that are indeterminate as carcinoma by needle biopsy before surgery and by study of frozen sections at the time of surgery are occasionally identified to be malignant in later studies. If only a lobectomy has been performed, the advisability of reoperation to remove the remaining thyroid tissue to facilitate radioactive iodine therapy may cause concern. To obviate this difficulty as well as to reduce the occurrence of nodules later in a preserved contralateral thyroid lobe and to provide additional thyroid tissue for study, contralateral subtotal or near total lobectomy has been performed for indeterminate thyroid nodules. The small remnant of remaining thyroid tissue can later be ablated by radioactive iodine if desired. Of 37 patients with indeterminate thyroid nodules, none required reoperation, although the diagnosis of carcinoma was established after surgery for eight patients, three of whom were treated with radioactive iodine.

• OSTI ID: 5768611
• Journal Information: Archives of Surgery (Chicago); (USA), Journal Name: Archives of Surgery (Chicago); (USA) Vol. 126:5; ISSN ARSUA; ISSN 0004-0010
• Country of Publication: United States
• Language: English

Related Subjects

550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
BODY
CALIFORNIA
CARCINOMAS
DEVELOPED COUNTRIES
DISEASES
ENDOCRINE GLANDS
FEDERAL REGION IX
GLANDS
HORMONES
IODINE ISOTOPES
ISOTOPES
MEDICINE
NEOPLASMS
NORTH AMERICA
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANS
PATIENTS
PEPTIDE HORMONES
PROTEINS
RADIOLOGY
RADIOTHERAPY
SURGERY
THERAPY
THYROID
THYROID HORMONES
THYROIDECTOMY
USA